Embed

Academic

Authors

Akihito Tsuji

Akihito Tsuji,Nagoya University,Oncology,Family Medicine,Anatomy

Edit

Akihito Tsuji

Nagoya University

Publications: 12 | Citations: 73

Fields: Oncology, Family Medicine, Anatomy

Collaborated with 84 co-authors from 1995 to 2012 | Cited by 441 authors

Cumulative Annual

Sort by:

Publications (12)

BibTeX | RIS | RefWorks Download

Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57352537&selfId1=24721870&selfId2=0&maxNumber=12&query=

Journal: Oncology - ONCOLOGY-BASEL , vol. 82, pp. 298-304, 2012

Phase II Study of Bolus 5Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=11551170&selfId1=24721870&selfId2=0&maxNumber=12&query=

Journal: Oncology - ONCOLOGY-BASEL , vol. 81, pp. 291-297, 2011

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) (Citations: 5)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=32112423&selfId1=24721870&selfId2=0&maxNumber=12&query=

Journal: Lancet Oncology - LANCET ONCOL , vol. 11, no. 9, pp. 853-860, 2010

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57379923&selfId1=24721870&selfId2=0&maxNumber=12&query=

Journal: Oncology - ONCOLOGY-BASEL , vol. 79, pp. 337-342, 2010

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate (Citations: 1)

, , , , , ,

Journal: International Journal of Clinical Oncology - INT J CLIN ONCOL , vol. 13, no. 4, pp. 355-360, 2008

Sort by:

Citations (73 times by 73 publications)

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma (Citations: 1)

, , , , , , , ,

Journal: Journal of Cancer Research and Clinical Oncology - J CANCER RES CLIN ONCOL , vol. 137, no. 4, pp. 659-667, 2011

Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302)

, , , , , , , , , , ,

Journal: Oncology - ONCOLOGY-BASEL , vol. 80, pp. 70-75, 2011

Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST

, , , , , , , ,

Journal: International Journal of Clinical Oncology - INT J CLIN ONCOL , vol. 16, no. 3, pp. 279-283, 2011

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=57379996&selfId1=24721870&selfId2=0&maxNumber=12&query=

Journal: Oncology - ONCOLOGY-BASEL , vol. 81, pp. 84-90, 2011

Unexpected Course of Nonlinear Cardiac Interbeat Interval Dynamics during Childhood and Adolescence

, , , , , ,

Journal: PLOS One , vol. 6, no. 5, 2011

Comments

Co-authors (84)

Journals (8)

Keywords (68)

Akihito Tsuji,Nagoya University,Oncology,Family Medicine,Anatomy

Publications (12)

BibTeX | RIS | RefWorks Download

Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy

Phase II Study of Bolus 5Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) (Citations: 5)

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate (Citations: 1)

Citations (73 times by 73 publications)

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma (Citations: 1)

Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302)

Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

Unexpected Course of Nonlinear Cardiac Interbeat Interval Dynamics during Childhood and Adolescence


	View FAQ about top research areas and Fields of study

Akihito Tsuji,Nagoya University,Oncology,Family Medicine,Anatomy

Publications (12) BibTeX | RIS | RefWorks Download

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) (Citations: 5)

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate (Citations: 1)

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma (Citations: 1)

Publications (12)

BibTeX | RIS | RefWorks Download